Dr Boon Vanasin insists a deal was in the works through a government agency. - Reuters
BANGKOK (Reuters): Thailand’s Thonburi Healthcare Group Pcl (THG) doubled down on its outspoken chairman's claim to be buying Pfizer-BioNTech vaccines on Friday (July 16), helping its share price rise despite denials by both drugmakers.
Dr Boon Vanasin's claim that his group, a more than US$800 million private medicine empire, was close to signing a deal for 20 million Pfizer-BioNTech coronavirus vaccines to import to Thailand was swiftly denied on Thursday by both companies, one day after a government agency filed a defamation suit against Boon, 82.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
